Managed Ventricular Pacing Protocol for Intrinsic Conduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional implantable medical devices often rely on extreme pacing modes that either neglect intrinsic conduction or preclude it, leading to excessive ventricular pacing, which can be detrimental and inefficient, particularly in patients with intact or partially intact AV conduction.
Innovation Solution
The implementation of Managed Ventricular Pacing (MVP) protocols, which promote intrinsic conduction by selectively operating in atrial-based pacing modes, minimizing ventricular pacing through the use of a post-atrial ventricular blanking period (PAVB) and crosstalk window management, allowing for accurate ventricular sensing and reducing unnecessary pacing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If DDD/R mode is used to maintain AV synchrony, then AV synchrony is improved, but ventricular pacing occurs in a very high percentage of cardiac cycles
Solution Approach 1:
The device dynamically switches between DDD/R and AAI/R modes based on real-time detection of intrinsic ventricular events. The pacing mode is not fixed but adapts to the patient's intrinsic conduction status, allowing the system to maintain AV synchrony when needed while promoting intrinsic conduction when possible, thereby reducing unnecessary ventricular pacing.
Solution Approach 2:
The system changes the operational parameters of the pacemaker by adjusting the pacing mode (DDD/R to AAI/R) based on detected ventricular events. This parameter change allows the device to transition from a mode that guarantees AV synchrony but causes excessive ventricular pacing to a mode that promotes intrinsic conduction while maintaining necessary pacing support.
2Reliability
If ventricular pacing is used to ensure cardiac support, then cardiac reliability is improved, but device power is consumed faster
Solution Approach 1:
The system allows intrinsic ventricular conduction to serve itself when possible by detecting native ventricular events and suppressing unnecessary ventricular pacing. The device monitors for intrinsic events and only provides ventricular pacing when truly needed, allowing the heart's natural conduction system to work without artificial intervention, thereby conserving battery power while maintaining cardiac reliability.
3Measurement precision
If post-atrial ventricular blanking period is extended to prevent crosstalk, then sensing accuracy is improved, but ventricular event detection is delayed
Solution Approach 1:
The system uses a truncated PAVB that is shorter than traditional settings, accepting some risk of crosstalk in exchange for faster ventricular event detection. This partial action approach balances the need for sensing accuracy with the need for timely detection of ventricular events, allowing the device to promote intrinsic conduction more effectively without excessive blanking time that would delay event detection.
Data Source
AI summary
An implantable medical device operates according to a ventricular pacing protocol (VPP) that precludes ventricular pacing in any cardiac cycle where a sensed ventricular event has occurred in the preceding cycle. Improved ventricular sensing, detection and classification is provided.